The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Sciatica 9
SANDOSTATIN LAR DEPOT Serum serotonin increased 9
SANDOSTATIN LAR DEPOT Short-bowel syndrome 9
SANDOSTATIN LAR DEPOT Spinal pain 9
SANDOSTATIN LAR DEPOT Vaginal haemorrhage 9
SANDOSTATIN LAR DEPOT Vitreous floaters 9
SANDOSTATIN Autonomic nervous system imbalance 8
SANDOSTATIN Chest discomfort 8
SANDOSTATIN Diabetes mellitus 8
SANDOSTATIN Discomfort 8
SANDOSTATIN Heart rate irregular 8
SANDOSTATIN Hyperhidrosis 8
SANDOSTATIN Injection site bruising 8
SANDOSTATIN Neoplasm 8
SANDOSTATIN Nervousness 8
SANDOSTATIN Product quality issue 8
SANDOSTATIN LAR DEPOT Accidental exposure to product 8
SANDOSTATIN LAR DEPOT Angina pectoris 8
SANDOSTATIN LAR DEPOT Arrhythmia 8
SANDOSTATIN LAR DEPOT Blood calcium increased 8

Total Records: 2,045     Number of Pages: 103